C200-1352 Screening compound: 2-[5-(2,4-difluorophenyl)-4,6-dioxo-1H,3aH,4H,5H,6H,6aH-pyrrolo[3,4-d][1,2,3]triazol-1-yl]-N-phenylacetamide

C200-1352 Screening compound: 2-[5-(2,4-difluorophenyl)-4,6-dioxo-1H,3aH,4H,5H,6H,6aH-pyrrolo[3,4-d][1,2,3]triazol-1-yl]-N-phenylacetamide
C200-1352 Screening compound: 2-[5-(2,4-difluorophenyl)-4,6-dioxo-1H,3aH,4H,5H,6H,6aH-pyrrolo[3,4-d][1,2,3]triazol-1-yl]-N-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C200-1352
2-[5-(2,4-difluorophenyl)-4,6-dioxo-1H,3aH,4H,5H,6H,6aH-pyrrolo[3,4-d][1,2,3]triazol-1-yl]-N-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C200-1352

Molecular Formula

C18H13F2N5O3 (C18 H13 F2 N5 O3)

Compound Name

2-[5-(2,4-difluorophenyl)-4,6-dioxo-1H,3aH,4H,5H,6H,6aH-pyrrolo[3,4-d][1,2,3]triazol-1-yl]-N-phenylacetamide

IUPAC name

2-[5-(24-difluorophenyl)-46-dioxo-1H3aH4H5H6H6aH-pyrrolo[34-d][123]triazol-1-yl]-N-phenylacetamide

SMILES

O=C(CN(C1C(N2c(ccc(F)c3)c3F)=O)N=NC1C2=O)Nc1ccccc1

InChI

InChI=1S/C18H13F2N5O3/c19-10-6-7-13(12(20)8-10)25-17(27)15-16(18(25)28)24(23-22-15)9-14(26)21-11-4-2-1-3-5-11/h1-8,15-16H,9H2,(H,21,26)

InChI Key

KVGZEYZZSVANHC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14726020

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

385.33

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.108

Distribution Coefficient, logD

1.108

Water Solubility, LogSw

-2.29

Polar Surface Area

80.221

Acid Dissociation Constant (pKa)

10.90

Base Dissociation Constant (pKb)

0.67

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

16.70

C200-1352 in Drug Discovery

Included in Screening Libraries

Cysteine Proteases Inhibitors Library (7839 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Proteases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C200-1352 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C200-1352?
Check Price and Availability of C200-1352, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C200-1352 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C200-1352
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C200-1352
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C200-1352 available by request